Filtered By:
Condition: Thrombosis
Procedure: Anesthesia
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 381 results found since Jan 2013.
Distal migration of the flow-redirection endoluminal device immediately after treatment: A case report and literature review
CONCLUSION: Distal migration of an FD in an acute setting, including the FRED, may occur even following appropriate placement. In-stent thrombosis can cause distal stent migration and thromboembolic stroke.PMID:35399895 | PMC:PMC8986641 | DOI:10.25259/SNI_1279_2021
Source: Surgical Neurology International - April 11, 2022 Category: Neurosurgery Authors: Yasuhiko Nariai Tomoji Takigawa Akio Hyodo Kensuke Suzuki Source Type: research
Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes
CONCLUSION: Tumescent-assisted endovenous laser ablation and foam sclerotherapy provides safe and effective outcomes in patients with a variety of VMs.PMID:35344460 | DOI:10.1177/02683555221080045
Source: Phlebology - March 28, 2022 Category: Internal Medicine Authors: Mina Kang David E Connor Kurosh Parsi Source Type: research
No Difference in Blood Loss and Risk of Transfusion Between Patients Treated with One or Two Doses of Intravenous Tranexamic Acid After Simultaneous Bilateral TKA
CONCLUSION: The findings of this study suggest that a single dose of intravenous TXA may be adequate to control excessive blood loss and reduce blood transfusion in simultaneous bilateral TKA. Despite its short half-life, TXA still appears to be effective in this demanding procedure without requiring prolonged plasma concentrations obtained from multiple doses. Additional high-quality studies are still needed to determine the most appropriate dosing regimen.LEVEL OF EVIDENCE: Level III, therapeutic study.PMID:35302971 | PMC:PMC8923576 | DOI:10.1097/CORR.0000000000002037
Source: Clinical Orthopaedics and Related Research - March 18, 2022 Category: Orthopaedics Authors: Jeffrey M Wilde Steven N Copp Kace A Ezzet Adam S Rosen Richard H Walker Julie C McCauley Audree S Evans William D Bugbee Source Type: research
The venous system during pregnancy. Part 1: physiologic considerations on the venous system
The confluence of anatomic and physiologic gestational changes, pre-existing and pregnancy-related comorbidities, surgery and anesthesia has significant implications for maternal hemodynamics. Genetic and hemodynamic factors alter endothelial migration and branching during embryogenesis to create separate venous and arterial systems, 1 which subsequently possess distinct responses to disease processes (e.g. venous insufficiency, thromboembolism, stroke). 2
Source: International Journal of Obstetric Anesthesia - February 24, 2022 Category: Anesthesiology Authors: L.C. Tsen, S. Gelman Tags: Review Article Source Type: research
Initial practice of left atrial appendage closure device in Japan; single-center experience
CONCLUSIONS: In this initial Japanese experience, LAAC therapy for high bleeding risk patients with NVAF seems feasible. Optimal antithrombotic regimens are warranted for better clinical outcomes.PMID:35094892 | DOI:10.1016/j.jjcc.2022.01.004
Source: Journal of Cardiology - January 31, 2022 Category: Cardiology Authors: Masato Fukunaga Akihiro Isotani Shinichi Shirai Naoto Murakami Miho Nakamura Takashi Morinaga Kenichi Ishizu Kazuki Kitano Tatsuhiro Kataoka Masaomi Hayashi Kenichi Hiroshima Kenji Ando Source Type: research
